Clinical proton MR spectroscopy in central nervous system disorders.
A large body of published work shows that proton (hydrogen 1 [(1)H]) magnetic resonance (MR) spectroscopy has evolved from a research tool into a clinical neuroimaging modality. Herein, the authors present a summary of brain disorders in which MR spectroscopy has an impact on patient management, tog...
Main Authors: | Oz, G, Alger, JR, Barker, P, Bartha, R, Bizzi, A, Boesch, C, Bolan, P, Brindle, K, Cudalbu, C, Dinçer, A, Dydak, U, Emir, U, Frahm, J, González, R, Gruber, S, Gruetter, R, Gupta, R, Heerschap, A, Henning, A, Hetherington, H, Howe, F, Hüppi, P, Hurd, R, Kantarci, K, Klomp, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2014
|
Similar Items
-
Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS
by: Emir, U, et al.
Published: (2012) -
Simultaneous measurement of glucose transport and utilization in the human brain
by: Shestov, A, et al.
Published: (2011) -
Multi-center reproducibility of neurochemical profiles in the human brain at 7 T.
by: van de Bank, B, et al.
Published: (2015) -
Two-site reproducibility of cerebellar and brainstem neurochemical profiles with short-echo, single-voxel MRS at 3T.
by: Deelchand, D, et al.
Published: (2014) -
Feasibility and comparison of 3D modified rosette ultra-short echo time (PETALUTE) with conventional weighted acquisition in 31 P-MRSI
by: Bozymski, B, et al.
Published: (2025)